| Dr Eka Rozentsvayg, DO | |
|
30 Prospect Ave, Radiology Dept, Hackensack, NJ 07601-1915 | |
| (000) 000-0000 | |
| Not Available |
| Full Name | Dr Eka Rozentsvayg |
|---|---|
| Gender | Female |
| Speciality | Diagnostic Radiology |
| Experience | 18 Years |
| Location | 30 Prospect Ave, Hackensack, New Jersey |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1255691655 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0202X | Radiology - Diagnostic Radiology | 25MB09110500 (New Jersey) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Hackensack University Medical Center | Hackensack, NJ | Hospital |
| Palisades Medical Center | North bergen, NJ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| New Century Imaging Llc | 4082517370 | 49 |
| Imaging North, Llc | 9133514987 | 31 |
| Hackensack Radiology Group Pa | 9830096361 | 42 |
News Archive
Pharmacyclics, Inc. has announced that it has begun treating patients in a Phase 1 dose-escalation study to evaluate the safety and tolerability of PCI-32765, an orally available, selective inhibitor of Bruton's tyrosine kinase, or Btk, as a potential treatment for patients with relapsed or refractory B-cell non-Hodgkin's lymphoma (NHL).
The power of taxane-based chemotherapy drugs are misunderstood and potentially underestimated, according to researchers at Weill Cornell Medical College in the September 15 issue of the journal Cancer Research.
Premiums in California's health insurance exchange will rise by an average of 8.7 percent next year, marking a return to more modest increases despite ongoing threats to the Affordable Care Act.
An international research consortium led by the Universitat Aut-noma de Barcelona (UAB), the CIBERER and the University of Wurzburg (Germany) has discovered a gene that can cause three totally different diseases, depending on how it is altered.
› Verified 6 days ago
| Entity Name | New Century Imaging Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1710909262 PECOS PAC ID: 4082517370 Enrollment ID: O20041209000031 |
News Archive
Pharmacyclics, Inc. has announced that it has begun treating patients in a Phase 1 dose-escalation study to evaluate the safety and tolerability of PCI-32765, an orally available, selective inhibitor of Bruton's tyrosine kinase, or Btk, as a potential treatment for patients with relapsed or refractory B-cell non-Hodgkin's lymphoma (NHL).
The power of taxane-based chemotherapy drugs are misunderstood and potentially underestimated, according to researchers at Weill Cornell Medical College in the September 15 issue of the journal Cancer Research.
Premiums in California's health insurance exchange will rise by an average of 8.7 percent next year, marking a return to more modest increases despite ongoing threats to the Affordable Care Act.
An international research consortium led by the Universitat Aut-noma de Barcelona (UAB), the CIBERER and the University of Wurzburg (Germany) has discovered a gene that can cause three totally different diseases, depending on how it is altered.
› Verified 6 days ago
| Entity Name | Hackensack Radiology Group Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1306864343 PECOS PAC ID: 9830096361 Enrollment ID: O20060417000055 |
News Archive
Pharmacyclics, Inc. has announced that it has begun treating patients in a Phase 1 dose-escalation study to evaluate the safety and tolerability of PCI-32765, an orally available, selective inhibitor of Bruton's tyrosine kinase, or Btk, as a potential treatment for patients with relapsed or refractory B-cell non-Hodgkin's lymphoma (NHL).
The power of taxane-based chemotherapy drugs are misunderstood and potentially underestimated, according to researchers at Weill Cornell Medical College in the September 15 issue of the journal Cancer Research.
Premiums in California's health insurance exchange will rise by an average of 8.7 percent next year, marking a return to more modest increases despite ongoing threats to the Affordable Care Act.
An international research consortium led by the Universitat Aut-noma de Barcelona (UAB), the CIBERER and the University of Wurzburg (Germany) has discovered a gene that can cause three totally different diseases, depending on how it is altered.
› Verified 6 days ago
| Entity Name | Imaging North, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1245835131 PECOS PAC ID: 9133514987 Enrollment ID: O20220315001152 |
News Archive
Pharmacyclics, Inc. has announced that it has begun treating patients in a Phase 1 dose-escalation study to evaluate the safety and tolerability of PCI-32765, an orally available, selective inhibitor of Bruton's tyrosine kinase, or Btk, as a potential treatment for patients with relapsed or refractory B-cell non-Hodgkin's lymphoma (NHL).
The power of taxane-based chemotherapy drugs are misunderstood and potentially underestimated, according to researchers at Weill Cornell Medical College in the September 15 issue of the journal Cancer Research.
Premiums in California's health insurance exchange will rise by an average of 8.7 percent next year, marking a return to more modest increases despite ongoing threats to the Affordable Care Act.
An international research consortium led by the Universitat Aut-noma de Barcelona (UAB), the CIBERER and the University of Wurzburg (Germany) has discovered a gene that can cause three totally different diseases, depending on how it is altered.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Eka Rozentsvayg, DO 130 Kinderkamack Rd Ste 200, River Edge, NJ 07661-1951 Ph: (201) 488-2660 | Dr Eka Rozentsvayg, DO 30 Prospect Ave, Radiology Dept, Hackensack, NJ 07601-1915 Ph: (000) 000-0000 |
News Archive
Pharmacyclics, Inc. has announced that it has begun treating patients in a Phase 1 dose-escalation study to evaluate the safety and tolerability of PCI-32765, an orally available, selective inhibitor of Bruton's tyrosine kinase, or Btk, as a potential treatment for patients with relapsed or refractory B-cell non-Hodgkin's lymphoma (NHL).
The power of taxane-based chemotherapy drugs are misunderstood and potentially underestimated, according to researchers at Weill Cornell Medical College in the September 15 issue of the journal Cancer Research.
Premiums in California's health insurance exchange will rise by an average of 8.7 percent next year, marking a return to more modest increases despite ongoing threats to the Affordable Care Act.
An international research consortium led by the Universitat Aut-noma de Barcelona (UAB), the CIBERER and the University of Wurzburg (Germany) has discovered a gene that can cause three totally different diseases, depending on how it is altered.
› Verified 6 days ago
Dr. Christopher I Song, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 30 Prospect Ave Radiology Dept, Hackensack, NJ 07601 Phone: 551-996-2200 | |
Dr. George J Ferrone, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 30 Prospect Ave, Radiology Dept, Hackensack, NJ 07601 Phone: 000-000-0000 | |
Dr. Jaskirat Singh Virk, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 30 Prospect Ave, Radiology Dept, Hackensack, NJ 07601 Phone: 000-000-0000 | |
Dr. David John Monoky, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 30 Prospect Ave, Radiology Dept, Hackensack, NJ 07601 Phone: 000-000-0000 | |
Dr. Narmadan Akileswaran Kumarasamy, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 30 Prospect Ave, Radiology Dept, Hackensack, NJ 07601 Phone: 000-000-0000 | |
Jacquelyn N Copeland, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 30 Prospect Ave Radiology Dept, Hackensack, NJ 07601 Phone: 551-996-2200 | |
Oreoluwa Ojutiku, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 30 Prospect Ave, Hackensack, NJ 07601 Phone: 201-996-2200 Fax: 201-489-2812 |